Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
INM
QNCX
Add up to 3 more stocks
INM
InMed Pharmaceuticals Inc.
0.00%
$1.330.00Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$7.31M
52W Range
$0.57 - $2.50
QNCX
Quince Therapeutics, Inc.
-2.62%
$27.36-0.74Delayed quote: Oct 6, 2026, 3:59 PM EDT
Market Cap
$7.62M
52W Range
$15.10 - $910.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 6.80 | N/A |
| P/S Ratio | 0.00 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 14.9% | 0.0% |
| Operating Margin | -0.5% | 0.0% |
| Net Margin | -0.6% | 0.0% |
| ROE | -1168.4% | -85.2% |
| ROA | -414.5% | -74.6% |
| ROIC | -995.4% | -107.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.37 | 14.52 |
| Quick Ratio | 1.37 | 14.52 |
| Debt/Equity | 0.00 | 0.00 |
| Interest Coverage | -924.78 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.